Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

Investigators assessed whether anticoagulation and platelet aggregation inhibition could have antitumoral effects when used along side targeted therapies for patients with unresectable stage III-IV ...

Although renal cell carcinoma (RCC) is more commonly found in adults older than 60 years, recent data show a rising rate of aggressive RCC among US adults aged 20 to 39 years. Cancer stage migration ...

Researchers sought to measure the confidence healthcare providers and patients have regarding future use of large-language ...

Increased infection risk seen with more liberalized diet for patients undergoing HSCT or induction chemotherapy for acute leukemia.

Dermatologists addressed the growing trend of misinformation regarding sunscreen use, as well as practical tips for ...

Improvement seen in quality of life and reduction in specific symptoms for adolescent and young adult breast cancer survivors.

Nurse Pretti, 37, spent his workdays as an intensive care unit nurse at the Department of Veterans Affairs in Minneapolis. He was protesting the presence of ICE agents, who have become an ominous ...

In this study, researchers matched patients using GLP-1RA therapy to those using aspirin to compare colorectal cancer incidence in each population.

Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...